UNSPSC 85561627: Supplement left inner ear with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left inner ear with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 09UE07Z

UNSPSC 85561627 Supplement left inner ear with autologous tissue substitute, open approach is a Commodity code that shows a disconnect between its nominal scope — a highly specialized surgical procedure — and recent state and local procurement activity. The recent opportunities block contains no solicitations for otologic surgical services, autologous tissue substitutes, or related medical devices or procedures. Instead, the tagged opportunities span comprehensive jail medical and pharmacy services (Muscogee County, Georgia), pharmacy benefit management for county employees (Collier County, Florida), virtual primary and urgent care platforms (Monroe County, Florida), peer support services for behavioral health workers (San Mateo County, California), and fire department medical direction (Santa Monica, California). None of these activities align with inner ear supplementation or otologic surgery.

State and local governments do not appear to be procuring under this code in recent activity. The code's narrow clinical specification — a specific surgical approach to a single anatomical site using autologous tissue — is inconsistent with the scale and scope of state and local healthcare contracting, which typically addresses broad service lines, benefit administration, or clinical staffing rather than point-of-care surgical procedures. If your firm pursues otologic implant or surgical-services procurement, verify that tagged opportunities are correctly coded before investing business development effort; this code shows no relevant recent solicitation volume.